Wall St Engine
$DLO NEARS $150M DEAL FOR AFRICA’S AZA FINANCE
DLocal is close to acquiring African payments firm AZA Finance for around $150M, in what would be its largest deal since 2021 and first outside Latin America. The move expands DLocal’s reach beyond its core LATAM markets, as it looks to deploy strong cash flow following better-than-expected Q1 results. AZA, founded in Nairobi, enables cross-border transactions in African currencies.
tweet
$DLO NEARS $150M DEAL FOR AFRICA’S AZA FINANCE
DLocal is close to acquiring African payments firm AZA Finance for around $150M, in what would be its largest deal since 2021 and first outside Latin America. The move expands DLocal’s reach beyond its core LATAM markets, as it looks to deploy strong cash flow following better-than-expected Q1 results. AZA, founded in Nairobi, enables cross-border transactions in African currencies.
tweet
Wall St Engine
$AGEN SELLS U.S. BIOLOGICS FACILITIES TO ZYDUS FOR UP TO $125M
Agenus is selling its biologics manufacturing sites in Emeryville and Berkeley, CA to Zydus Lifesciences for $75M upfront, plus up to $50M in milestone payments. Zydus gains a U.S. base for its new CDMO business and will exclusively manufacture Agenus’ Phase 3-ready cancer drugs Botensilimab and Balstilimab. The deal gives Zydus a foothold in the growing global biologics market.
tweet
$AGEN SELLS U.S. BIOLOGICS FACILITIES TO ZYDUS FOR UP TO $125M
Agenus is selling its biologics manufacturing sites in Emeryville and Berkeley, CA to Zydus Lifesciences for $75M upfront, plus up to $50M in milestone payments. Zydus gains a U.S. base for its new CDMO business and will exclusively manufacture Agenus’ Phase 3-ready cancer drugs Botensilimab and Balstilimab. The deal gives Zydus a foothold in the growing global biologics market.
tweet
Offshore
Photo
Wall St Engine
Apple $AAPL is reportedly in talks with Perplexity to bring its AI search to iPhones—potentially replacing Google $GOOGL in Safari and ChatGPT in Siri. https://t.co/cDjPyNuNYs
tweet
Apple $AAPL is reportedly in talks with Perplexity to bring its AI search to iPhones—potentially replacing Google $GOOGL in Safari and ChatGPT in Siri. https://t.co/cDjPyNuNYs
tweet
Offshore
Photo
Wall St Engine
PayPal $PYPL is rolling out a physical PayPal Credit card, issued by Synchrony $SYF, letting users tap their credit line in stores and anywhere Mastercard is accepted.
The launch includes a limited-time offer for six-month promotional financing on travel with no minimum spend. This expands PayPal Credit beyond online use as demand grows for more flexible, on-the-go payment options.
tweet
PayPal $PYPL is rolling out a physical PayPal Credit card, issued by Synchrony $SYF, letting users tap their credit line in stores and anywhere Mastercard is accepted.
The launch includes a limited-time offer for six-month promotional financing on travel with no minimum spend. This expands PayPal Credit beyond online use as demand grows for more flexible, on-the-go payment options.
tweet
Offshore
Photo
Wall St Engine
Trump: Rand Paul has very little understanding of the BBB, especially the tremendous GROWTH that is coming. He loves voting “NO” on everything, he thinks it’s good politics, but it’s not. The BBB is a big WINNER!!! https://t.co/eQBkQdu8j3
tweet
Trump: Rand Paul has very little understanding of the BBB, especially the tremendous GROWTH that is coming. He loves voting “NO” on everything, he thinks it’s good politics, but it’s not. The BBB is a big WINNER!!! https://t.co/eQBkQdu8j3
tweet
Offshore
Photo
Wall St Engine
WEGOVY USE JUMPS 50% AMONG U.S. TEENS IN 2024
New data from Truveta shows teen prescriptions for $NVO Wegovy rose to 14.8 per 100K last year, up from 9.9 in 2023, with Q1 2025 already averaging 17.3. Still, that's a fraction of the 23,000 per 100K teens with obesity nationwide. Doctors remain divided, citing limited access, unclear long-term safety, and insurance gaps. But for some, the drug’s shown solid results—patients at one clinic averaged 15 to 30 lbs lost over a year.
tweet
WEGOVY USE JUMPS 50% AMONG U.S. TEENS IN 2024
New data from Truveta shows teen prescriptions for $NVO Wegovy rose to 14.8 per 100K last year, up from 9.9 in 2023, with Q1 2025 already averaging 17.3. Still, that's a fraction of the 23,000 per 100K teens with obesity nationwide. Doctors remain divided, citing limited access, unclear long-term safety, and insurance gaps. But for some, the drug’s shown solid results—patients at one clinic averaged 15 to 30 lbs lost over a year.
tweet